NEWTON, Mass.--(BUSINESS WIRE)--Novelos Therapeutics, Inc. (OTCBB: NVLT), a biopharmaceutical company focused on the development of therapeutics to treat cancer and hepatitis, today announced that Harry S. Palmin, President and CEO of Novelos, will present at Merriman Curhan Ford’s 5th annual Investor Summit on September 15, 2008. Mr. Palmin is scheduled to present at 8am PDT (11am EDT) in Track 1 – California Room. Mr. Palmin will also participate in a panel discussion “What’s Next on the Horizon in Biotech?” at 1:45pm PDT. This event will be held at the Mark Hopkins InterContinental Hotel in San Francisco.
